• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Doxx to collect initial bids amid fierce midmarket sponsor interest

  • Patrick Costello and Johannes Koch
  • 28 February 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Doxx, a German digital healthcare staffing specialist, is drawing interest from a swathe of private equity players as it gears up to collect indicative this week, four sources familiar with the situation said.

Non-binding offers for the privately-held company are due today (28 February), the first two sources said.

IK Partners, Deutsche Private Equity, Ardian, Chequers, Triton, PAI, Equistone and Rivean Capital (formerly known as Gilde Buy Out Partners) are among the extensive list of midmarket-focused sponsors expected to submit offers for Doxx, the sources said.

Given the competitive nature of the auction, some of the keenest bidders have already submitted initial offers, the first source said.

“This is a process where you need to be in the lead, not just hanging in,” the source continued.

Doxx is being marketed off FY21 EBITDA of EUR 14m in the Alantra-led sale, based on LTM to October 2021, as reported. It was expected to be marketed off EUR 15m-EUR 20m EBITDA in pre-sale chatter, the news service wrote in November. "The truth lies somewhere in the middle," one of the sources said.

A confluence of factors has made Doxx an exceptionally attractive proposition, as reported. It operates in a market with long-term growth prospects as hospitals continue to rely on temporary staffing to plug supply gaps and no regulatory risks stand in the way of this development. It is further boosted by being the number two in its sector in Germany behind the highly regarded number one player doctari, a Vitruvian-backed healthcare staffing platform.

The German market for digital healthcare staffing is likewise less developed than in countries like the UK, one of the sources said. “So two things are coming together here, a hot sector and a German market that needs to play catchup,” the sources continued, adding “you probably can’t go wrong with this.”

Still, Doxx lacks some uniqueness and its likeness to Doctari could be considered a liability, as reported.

"It’s a hot asset but, at the end of the day, it’s a couple guys facilitating the movement of doctors across hospitals,” the first source commented.

Founded in 2010, Heidelberg-based Doxx is owned and run by founder Konrad Schumm. It has 75 employees supporting the placement of medical staff and doctors at hospitals, clinics and medical practices in Germany.

Doxx reported EUR 8.5m EBIT on the back of EUR 41.5m sales in 2019, nearly double the EUR 4.5m EBIT and EUR 22.5m sales it booked in 2018, according to its most recently available financial filings.

IK, Ardian, Triton, PAI and Equistone declined to comment. Alantra, Doxx, Chequers, Deutsche Private Equity and Rivean did not respond to a request for comment.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Healthcare
  • DACH
  • Germany
  • IK Investment Partners
  • Ardian (formerly Axa PE)
  • Gilde Buy Out Partners
  • Deutsche Private Equity
  • Chequers Capital
  • Triton Partners
  • PAI Partners
  • Equistone Partners Europe

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013